Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT01530802
Eligibility Criteria:
Inclusion Criteria:
* Patients are eligible for the study when between 18 and 50 years of age,
* diagnosed with either symptomatic or asymptomatic leiomyomata, and with desire to keep the uterus, and whose leiomyomata had a minimal combined diameter of ≥ 4 cm.
Exclusion Criteria:
* patients with severe accompanying medical problems, or
* with psychiatric illnesses, which jeopardize the participation, or
* undergoing treatment affecting coagulation and/or hematopoiesis, and
* patients with suspected malignancy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT01530802
Study Brief:
Protocol Section:
NCT01530802